Skip to main content
Type at least 3 characters

1,199 articles

Brief Research Report

Published on 02 Feb 2022

The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile

in Gastrointestinal and Hepatic Pharmacology

  • Alana AragĂłn-Herrera
  • Manuel Otero-Santiago
  • Laura Anido-Varela
  • Sandra Moraña-Fernández
  • Manuel Campos-Toimil
  • Tomás GarcĂ­a-Caballero
  • Luis Barral
  • EstefanĂ­a TarazĂłn
  • Esther RosellĂł-LletĂ­
  • Manuel PortolĂ©s
Frontiers in Pharmacology
doi 10.3389/fphar.2022.827033
  • 5,099 views
  • 5 citations